| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 服务收入(元) | 9,381,583.67 | 3,097,887.14 | 6,029,915.80 | 4,396,938.43 |
| 销售商品收入(元) | 1,015,007.56 | 867,058.42 | 4,956,541.68 | 3,886,963.52 |
| 药品收入(元) | 5,798,311.46 | 2,451,180.00 | 7,572,718.70 | 2,474,219.83 |
| 医疗收入(元) | 51,675,469.38 | 18,413,827.50 | 36,772,211.59 | 18,799,365.85 |
| 营业成本(元) | ||||
| 服务收入(元) | 1,711,784.77 | 921,341.05 | 4,122,073.17 | 2,738,164.06 |
| 销售商品收入(元) | 1,422,248.83 | 2,094,553.88 | 1,449,712.17 | 956,151.77 |
| 药品收入(元) | 5,871,905.06 | 2,421,773.48 | 5,467,220.22 | 2,630,375.73 |
| 医疗收入(元) | 54,807,768.78 | 23,005,634.83 | 42,166,872.41 | 17,944,593.25 |
| 毛利(元) | ||||
| 服务收入(元) | 7,669,798.90 | 2,176,546.09 | 1,907,842.63 | 1,658,774.37 |
| 销售商品收入(元) | -407,241.27 | -1,227,495.46 | 3,506,829.51 | 2,930,811.75 |
| 药品收入(元) | -73,593.60 | 29,406.52 | 2,105,498.48 | -156,155.90 |
| 医疗收入(元) | -3,132,299.40 | -4,591,807.33 | -5,394,660.82 | 854,772.60 |
| 毛利率(%) | ||||
| 服务收入(%) | 81.75 | 70.26 | 31.64 | 37.73 |
| 销售商品收入(%) | -40.12 | -141.57 | 70.75 | 75.40 |
| 药品收入(%) | -1.27 | 1.20 | 27.80 | -6.31 |
| 医疗收入(%) | -6.06 | -24.94 | -14.67 | 4.55 |
| 收入构成(%) | ||||
| 服务收入(%) | 13.82 | 12.48 | 10.90 | 14.88 |
| 销售商品收入(%) | 1.50 | 3.49 | 8.96 | 13.15 |
| 药品收入(%) | 8.54 | 9.87 | 13.69 | 8.37 |
| 医疗收入(%) | 76.14 | 74.16 | 66.46 | 63.60 |
| 毛利构成(%) | ||||
| 服务收入(%) | 189.07 | - | 89.76 | 31.37 |
| 销售商品收入(%) | -10.04 | - | 164.99 | 55.42 |
| 药品收入(%) | -1.81 | - | 99.06 | -2.95 |
| 医疗收入(%) | -77.21 | - | -253.81 | 16.16 |